OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: John "Kent" Werner

1 Projects | 1 Researchers | $188,193 Invested

2018

Cogentis Therapeutics

John "Kent" Werner, MD, PhD

Preclinical pharmacokinetics and pharmacodynamics of CT-526 in the tauopathy mouse model

  • Funding Amount: $188,193
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Neuronal Degeneration
  • Status: Closed